(American Academy of Otolaryngology -- Head and Neck Surgery) Featuring more than 305 scientific research sessions, 594 posters and several hundred instruction course hours for attendees, the annual meeting is a unique opportunity for journalists from around the world to cover...
Business is there: moving from $300M in 2009 to $1.2B in 2015 only for smart phones
Duluth-Area Plasma Donors to be Recognized for Lifesaving Contribution in Fight Against Rare DiseasesSeptember 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments
DULUTH, Minn., Sept. 25 /- CSL Plasma , one of the world's largest collectors of human plasma, is honoring donors from the Duluth area today as part of a statewide observance of "Plasma Protein Therapies Month." According to Randy Furby, Senior Vice President and General Manager of CSL...
HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack PatientsSeptember 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments
NATICK, Mass., Sept. 25 /- Boston Scientific Corporation (NYSE: BSX ) today announced three-year follow-up data from the HORIZONS-AMI trial. The trial, sponsored by the Cardiovascular Research Foundation (CRF) with grant support from Boston Scientific and The Medicines Company...
Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT ...September 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments
WASHINGTON, Sept. 25 /- OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell (EPC) capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture...
HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack PatientsSeptember 25, 2010 9:31 am | by Boston Scientific | News | Comments
NATICK, Mass., Sept. 25 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced three-year follow-up data from the HORIZONS-AMI trial. The trial, sponsored by the Cardiovascular Research Foundation (CRF) wi
Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardi...September 25, 2010 7:31 am | by Bio-Medicine.Org | News | Comments
PHILADELPHIA, Sept. 25 /- Today Astellas Pharma US, Inc. ("Astellas") announced results of a Phase IV study showing Lexiscan® (regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or...
Recall due to risks of embolic, thrombotic and other vascular serious adverse events.
AACR Applauds Appointment of Ellen V. Sigal, Ph.D., to the Patient-Centered Outcomes Research Institute Board of GovernorsSeptember 24, 2010 3:33 pm | by AACR | News | Comments
WASHINGTON, D.C. — The American Association for Cancer Research applauds the appointment of Ellen V. Sigal, Ph.D., chairperson and founder of the Friends of Cancer Research, to the board of governors for the new Patient-Centered Outcomes Research Institute (PCORI).
WASHINGTON, D.C. — AACR President-elect Judy E. Garber, M.D., M.P.H., testified on Sept. 22 before the President's Cancer Panel, "The Future of Cancer Research: Accelerating Scientific Innovation." The panel is exploring progress achieved since the National Cancer Act of 1971, and...
The world's most precise clocks can reveal tiny time dilations predicted by Einstein's theory of relativity -- but that's not all. Tom O'Brian of the National Institute for Standards and Technology talks about using these precise clocks in everything from cell phones to satellites.
Humans and chimpanzees share very similar genes -- some analyses peg the differences at just 1 percent. But in his book Almost Chimpanzee, science writer Jon Cohen focuses on our differences, from the way we eat and communicate to our susceptibilities to disease and aging.
Personalized medicine promises to deliver more tailored health care. But what if a person's genes reveal he won't get much benefit from the only available treatment? Ethicist Leonard Fleck discusses the tough decisions Americans face in deciding whether to pay for others' expensive treatments.
Three separate rigs are drilling escape shafts to free the 33 miners trapped half a mile beneath the Atacama desert in Chile. Mine safety advocate Davitt McAteer and drilling engineer Rudy Lyon discuss the technology being used in the rescue and how miners can be kept out of harm's way.
Many police departments use forensic artists to help solve crimes. From composite sketches to facial reconstructions, the work of these artists combines creativity, science and detective skills. Artist Karen T. Taylor and anthropologist Mary Manhein discuss the science behind forensic art.